Girihlet is a startup. Brouky records 2 investors associated with the company.
Girihlet develops ImmuneScanner, a diagnostic tool to monitor autoimmune treatments and help patients and doctors select the best options. They collaborate with Mayo Clinic to study treatment effects on Ankylosing Spondylitis and create platforms for discovering strategies for complex immune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.